Aim Immunotech (AIM) revenue and earnings history
Aim Immunotech reported revenue of $88K for fiscal 2025 (year ended Dec 31, 2025), −48.2% on the year before, and net income of −$14M.
Over 16 years, from fiscal 2009 to fiscal 2025, revenue grew at a compound rate of −1.4% a year.
Revenue and net income, 17 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $88K−48.2% | −$11.7M | −$14M | −$11M | — | — | $60K | — | — | $2.98M | $4.48M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Aim Immunotech (AIM) on OQRO.
Common questions
What was Aim Immunotech's revenue in fiscal 2025?
$88K for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 27, 2026. That is −48.2% on fiscal 2024 ($170K).
How fast has Aim Immunotech's revenue grown?
From $111K in fiscal 2009 to $88K in fiscal 2025: a compound annual growth rate of −1.4% over 16 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Aim Immunotech been profitable?
It reported a net loss in 13 of the years shown (2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$7.5M in fiscal 2016.
Where these figures come from
The SEC’s companyfacts data: every figure Aim Immunotech tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
